<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00725218</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-MZ203</org_study_id>
    <secondary_id>M089732</secondary_id>
    <nct_id>NCT00725218</nct_id>
  </id_info>
  <brief_title>Flurbiprofen Axetil for Uterine Contraction Pain</brief_title>
  <acronym>FAUCOP</acronym>
  <official_title>Phase IV Study of Flurbiprofen Axetil for Uterine Contraction Pain After Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Uterine contraction pain is a common problem after abortion. Optimal analgesic for such
      suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable
      non-steroidal anti-inflammatory drug (NSAID) functioning via block the synthesis of
      prostaglandin E (PGE). The investigators hypothesized that Flurbiprofen Axetil could suppress
      the uterine contraction pain after abortion effectively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS pain scorings</measure>
    <time_frame>At the end of the operation, 0,5,15,30,60min after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anesthetic consumptions</measure>
    <time_frame>At the end of the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall VAS satisfaction scorings with analgesia</measure>
    <time_frame>At the end of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>During the whole period of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of bleeding</measure>
    <time_frame>At the end of the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">97</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline 5 ml injection 10 min prior to propofol administration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Flurbiprofen Axetil 50 mg in 5 ml injection 10min prior to propofol administration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline 5 ml injection 10 min prior to propofol administration.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Ringer's solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flurbiprofen Axetil</intervention_name>
    <description>Flurbiprofen Axetil 50 mg in 5 ml injection 10min prior to propofol administration.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>KaiFen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA status I-II

          -  Performing abortion operation (medical- or drug-induced

          -  Requiring painless abortion

        Exclusion Criteria:

          -  &lt; 19yrs, and &gt;= 45yrs

          -  History of central active drugs administration

          -  Drug abuse

          -  Hypertension

          -  Diabetes

          -  Any other chronic diseases

          -  Allergy to the study drugs

          -  Habit of over-volume alcohol drinking

          -  Records of history of centrally active drug use and psychiatry

          -  Any organic disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2008</study_first_submitted>
  <study_first_submitted_qc>July 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2008</study_first_posted>
  <last_update_submitted>August 5, 2008</last_update_submitted>
  <last_update_submitted_qc>August 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2008</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Maternal and Child Health Hospital</organization>
  </responsible_party>
  <keyword>NSAIDs</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Abortion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Flurbiprofen</mesh_term>
    <mesh_term>Flurbiprofen axetil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

